{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:27:54Z","timestamp":1759883274895,"version":"build-2065373602"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,7]]},"DOI":"10.7759\/cureus.94038","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T16:25:02Z","timestamp":1759854302000},"source":"Crossref","is-referenced-by-count":0,"title":["Management of Primary and Secondary Hyperparathyroidism in a Patient With Chronic Kidney Disease (CKD)"],"prefix":"10.7759","author":[{"given":"Bashirat O","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunggeun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-016-3716-2","article-title":"Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus","volume":"28","author":"Khan AA","year":"2017","unstructured":"Khan AA, Hanley DA, Rizzoli R, et al.. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int. 2017, 28:1-19. 10.1007\/s00198-016-3716-2","journal-title":"Osteoporos Int"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.490","article-title":"Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets","volume":"81","author":"Spiegel DM","year":"2012","unstructured":"Spiegel DM, Brady K. Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets. Kidney Int. 2012, 81:1116-22. 10.1038\/ki.2011.490","journal-title":"Kidney Int"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"7","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group","year":"2017","unstructured":"Kidney Disease. Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group: KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl (2011). 2017, 7:1-59. 10.1016\/j.kisu.2017.04.001","journal-title":"Kidney Int Suppl (2011)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000116623","article-title":"Minireview on regulation of intestinal calcium absorption. Emphasis on molecular mechanisms of transcellular pathway","volume":"77","author":"P\u00e9rez AV","year":"2008","unstructured":"P\u00e9rez AV, Picotto G, Carpentieri AR, Rivoira MA, Peralta L\u00f3pez ME, Tolosa de Talamoni NG. Minireview on regulation of intestinal calcium absorption. Emphasis on molecular mechanisms of transcellular pathway. Digestion. 2008, 77:22-34. 10.1159\/000116623","journal-title":"Digestion"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1215","article-title":"The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years","volume":"93","author":"Rubin MR","year":"2008","unstructured":"Rubin MR, Bilezikian JP, McMahon DJ, et al.. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab. 2008, 93:3462-70. 10.1210\/jc.2007-1215","journal-title":"J Clin Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4677","article-title":"Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the Fifth International Workshop","volume":"37","author":"Bilezikian JP","year":"2022","unstructured":"Bilezikian JP, Khan AA, Silverberg SJ, et al.. Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the Fifth International Workshop. J Bone Miner Res. 2022, 37:2293-314. 10.1002\/jbmr.4677","journal-title":"J Bone Miner Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1836","article-title":"Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial","volume":"92","author":"Bollerslev J","year":"2007","unstructured":"Bollerslev J, Jansson S, Mollerup CL, et al.. Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab. 2007, 92:1687-92. 10.1210\/jc.2006-1836","journal-title":"J Clin Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0028","article-title":"Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism","volume":"89","author":"Rao DS","year":"2004","unstructured":"Rao DS, Phillips ER, Divine GW, Talpos GB. Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab. 2004, 89:5415-22. 10.1210\/jc.2004-0028","journal-title":"J Clin Endocrinol Metab"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-67-6-1294","article-title":"Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course","volume":"67","author":"Rao DS","year":"1988","unstructured":"Rao DS, Wilson RJ, Kleerekoper M, Parfitt AM. Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course. J Clin Endocrinol Metab. 1988, 67:1294-8. 10.1210\/jcem-67-6-1294","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.80.3.7883824","article-title":"Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism","volume":"80","author":"Silverberg SJ","year":"1995","unstructured":"Silverberg SJ, Gartenberg F, Jacobs TP, et al.. Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism. J Clin Endocrinol Metab. 1995, 80:729-34. 10.1210\/jcem.80.3.7883824","journal-title":"J Clin Endocrinol Metab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.12.014","article-title":"Incidence, predictors and therapeutic consequences of hypocalcemia in patients treated with cinacalcet in the EVOLVE trial","volume":"93","author":"Floege J","year":"2018","unstructured":"Floege J, Tsirtsonis K, Iles J, Drueke TB, Chertow GM, Parfrey P. Incidence, predictors and therapeutic consequences of hypocalcemia in patients treated with cinacalcet in the EVOLVE trial. Kidney Int. 2018, 93:1475-82. 10.1016\/j.kint.2017.12.014","journal-title":"Kidney Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001436","article-title":"Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials","volume":"10","author":"Palmer SC","year":"2013","unstructured":"Palmer SC, Nistor I, Craig JC, et al.. Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials. PLoS Med. 2013, 10:e1001436. 10.1371\/journal.pmed.1001436","journal-title":"PLoS Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021597","article-title":"The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism","volume":"88","author":"Shoback DM","year":"2003","unstructured":"Shoback DM, Bilezikian JP, Turner SA, McCary LC, Guo MD, Peacock M. The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism. J Clin Endocrinol Metab. 2003, 88:5644-9. 10.1210\/jc.2002-021597","journal-title":"J Clin Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4685","article-title":"The efficacy and safety of medical and surgical therapy in patients with primary hyperparathyroidism: a systematic review and meta-analysis of randomized controlled trials","volume":"37","author":"Ye Z","year":"2022","unstructured":"Ye Z, Silverberg SJ, Sreekanta A, et al.. The efficacy and safety of medical and surgical therapy in patients with primary hyperparathyroidism: a systematic review and meta-analysis of randomized controlled trials. J Bone Miner Res. 2022, 37:2351-72. 10.1002\/jbmr.4685","journal-title":"J Bone Miner Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12030189","article-title":"Parathyroid hormone: a uremic toxin","volume":"12","author":"Duque EJ","year":"2020","unstructured":"Duque EJ, Elias RM, Moys\u00e9s RM. Parathyroid hormone: a uremic toxin. Toxins (Basel). 2020, 12:189. 10.3390\/toxins12030189","journal-title":"Toxins (Basel)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfac236","article-title":"Treatment of secondary hyperparathyroidism in non-dialysis CKD: an appraisal 2022s","volume":"38","author":"Ketteler M","year":"2023","unstructured":"Ketteler M, Bover J, Mazzaferro S. Treatment of secondary hyperparathyroidism in non-dialysis CKD: an appraisal 2022s. Nephrol Dial Transplant. 2023, 38:1397-404. 10.1093\/ndt\/gfac236","journal-title":"Nephrol Dial Transplant"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007111164","article-title":"Association of oral calcitriol with improved survival in nondialyzed CKD","volume":"19","author":"Shoben AB","year":"2008","unstructured":"Shoben AB, Rudser KD, de Boer IH, Young B, Kestenbaum B. Association of oral calcitriol with improved survival in nondialyzed CKD. J Am Soc Nephrol. 2008, 19:1613-9. 10.1681\/ASN.2007111164","journal-title":"J Am Soc Nephrol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1053\/j.jrn.2019.09.001","article-title":"Antiproteinuria effect of calcitriol in patients with chronic kidney disease and vitamin D deficiency: a randomized controlled study","volume":"30","author":"Wu CC","year":"2020","unstructured":"Wu CC, Liao MT, Hsiao PJ, Lu CL, Hsu YJ, Lu KC, Chu P. Antiproteinuria effect of calcitriol in patients with chronic kidney disease and vitamin D deficiency: a randomized controlled study. J Ren Nutr. 2020, 30:200-7. 10.1053\/j.jrn.2019.09.001","journal-title":"J Ren Nutr"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-801028-0.00236-1","article-title":"Subchapter 97A - calcitriol","author":"Ohyama Y","year":"2016","unstructured":"Ohyama Y, Shinki T. Subchapter 97A - calcitriol. Handbook of Hormones: Comparative Endocrinology for Basic and Clinical Research. Takei Y, Ando H, Tsutsui K (ed): Academic Press, London, UK; 2016. 548-50, e97A-1-e97A-5. 10.1016\/B978-0-12-801028-0.00236-1"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01040308","article-title":"Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results","volume":"3","author":"Fishbane S","year":"2008","unstructured":"Fishbane S, Shapiro WB, Corry DB, et al.. Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results. Clin J Am Soc Nephrol. 2008, 3:1718-25. 10.2215\/CJN.01040308","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/374531-management-of-primary-and-secondary-hyperparathyroidism-in-a-patient-with-chronic-kidney-disease-ckd","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T16:25:03Z","timestamp":1759854303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/374531-management-of-primary-and-secondary-hyperparathyroidism-in-a-patient-with-chronic-kidney-disease-ckd"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.94038","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,7]]}}}